Search the Newsreel

Amphastar Pharmaceuticals (NASDAQ: AMPH) Q2 revenue rises 5% with margin gains

Amphastar Pharmaceuticals reported a 5% increase in Q2 2026 net revenues to $183.9 million, driven by growth in new products like Ipratropium bromide, despite declines in others such as BAQSIMI and Glucagon. The company achieved a gross margin expansion to 50.8%, although GAAP net …

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Amphastar Pharmaceuticals, Inc. reported net revenues of $183.9 million for the second quarter of 2026, marking a 5% increase year-over-year. GAAP net income was $30.3 million ($0.67 per share), while adjusted non-GAAP net income reached $40.8 million ($0.91 per share). The company highlighted continued …

Amphenol (APH) sube un 14,6 % tras superar las previsiones de ventas impulsadas por la IA, una división de acciones y un aumento del dividendo: ¿ha cambiado el panorama alcista?

Amphenol (APH) Is Up 14.6% After AI-Fueled Sales Beat, Stock Split And Dividend Hike - Has The Bull Case Changed?

Amphenol Board Approves Stock Split; Announces Q3 Adj. EPS Guidance Following Stock Split

(RTTNews) - Amphenol (APH) announced that its Board approved a two-for-one stock split to be paid in the form of a stock dividend. Each Amphenol shareholder of record at the close of business on August 17, 2026 will receive one additional share for every …

Amphenol Announces Two-for-One Stock Split and Third Quarter 2026 Dividend

WALLINGFORD, Conn., August 06, 2026--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) today announced that at its meeting held on August 5, 2026, the Company's Board of Directors approved a two-for-one stock split to be paid in the form of a stock dividend. Each Amphenol shareholder of …

Pacer Advisors Inc. Buys 83,739 Shares of Amphastar Pharmaceuticals, Inc. $AMPH

Pacer Advisors Inc. increased its stake in Amphastar Pharmaceuticals by 47.1% in the first quarter, purchasing 83,739 additional shares, bringing its total holdings to 261,483 shares valued at approximately $5.1 million. Despite this institutional interest, analyst sentiment remains cautious with a "Reduce" consensus rating …

Astera Labs and Amphenol: Quiet AI Capex Tax Collectors to Know Before Others Catch On

The article analyzes Astera Labs (ALAB) and Amphenol (APH) as beneficiaries of AI infrastructure spending. Astera Labs, focused on AI fabric silicon, saw revenue double year over year, while Amphenol, with diversified offerings, grew 55% to $8.76 billion. The author suggests Astera offers higher …

Amphastar Pharmaceuticals (AMPH) Earnings Date and Reports 2026

Amphenol (APH) Stock Looks Fair On Earnings But Expensive Elsewhere

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Amphenol stock has delivered very strong gains over the past few years, yet its latest valuation checks suggest the shares now lean expensive …

Amphenol (APH) Stock Looks Fairly Valued As Earnings Hold Up After A 387% Run

Weekly Recap: Record $10.732B orders and broker price-target raises

Amphenol Corporation (NYSE: APH) reported record orders of $10.732 billion, a 94% year-over-year increase, with a strong 1.23 book-to-bill ratio and GAAP operating income of $2.6 billion. This impressive performance led four brokers, including Citigroup, UBS, Truist, and BNP Paribas, to raise their price …

Why Amphenol (APH) Might be Well Poised for a Surge

Amphenol (APH) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company. Analysts' growing optimism on the earnings …

What Makes Amphenol (APH) a Strong Momentum Stock: Buy Now?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …

5 Must-Read Analyst Questions From Amphenol’s Q2 Earnings Call

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook Reveals 8.80% Upside Potential

Amphastar Pharmaceuticals (NASDAQ: AMPH) is a biopharmaceutical company with a diverse product portfolio showing an 8.80% upside potential from its current stock price of $20.22, with an average target price of $22.00. Despite its strong free cash flow and return on equity, caution is …

Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly increased its stake in Amphastar Pharmaceuticals (NASDAQ:AMPH) by 12.7% in the first quarter, now owning over 2 million shares. Despite this institutional interest, Amphastar's recent quarterly earnings missed analyst expectations for both EPS and revenue, contributing to a "Reduce" …

APH Q2 Deep Dive: AI Datacenter Demand and CommScope Acquisition Propel Growth

APH Q2 Deep Dive: AI Datacenter Demand and CommScope Acquisition Propel Growth Electrical connector manufacturer Amphenol (NYSE:APH) announced better-than-expected revenue in Q2 CY2026, with sales up 55% year on year to $8.76 billion. On top of that, next quarter's revenue guidance ($9.35 billion at …

Arrowstreet Capital Limited Partnership Has $6.37 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH

Arrowstreet Capital Limited Partnership reduced its stake in Amphastar Pharmaceuticals by 41.9% in Q1 2026, holding 325,291 shares valued at $6.37 million. Despite this, institutional ownership remains high at 65.09%, with other firms like Dimensional Fund Advisors and State Street increasing their positions. The …

ETFs Investing in Amphenol Corporation Class A Stocks

This article lists various ETFs that include Amphenol Corporation Class A (XPH) stocks in their holdings. The ETFs are sorted by market value and provide details such as weight, issuer, management style, expense ratio, AUM, price, change percentage, and 3-year NAV total return. This …

¿Sigue Infravalorada Amphenol (APH) Tras Sus Resultados Récord Y Su Sólida Guía?

Amphenol’s Q2 Earnings Beat Every Estimate. The CommScope Bet Is Paying Off Faster Than Expected.

Amphenol (APH) insider Norwitt plans $30.2M Form 144 stock sale

Richard Adam Norwitt, an insider at Amphenol Corporation (APH), has filed a Form 144 notice to sell 186,104 shares of common stock, valued at approximately $30.2 million. This sale, scheduled for on or after July 31, 2026, is related to the exercise of options …

Amphenol Builds AI Edge Through Strategic Acquisitions: What's Ahead?

Amphenol's APH acquisition strategy is strengthening its prospects by expanding product portfolio, addressable markets and customer relationships. The additions have broadened APH's exposure across IT datacom, communications networks, industrial, defense and commercial aerospace markets, reducing dependence on any single application while creating cross-selling opportunities …

Does Record Q2 Results And AI-Driven Guidance Shift The Bull Case For Amphenol (APH)?

In late July 2026, Amphenol Corporation reported second-quarter 2026 results showing record sales of US$8.76 billion and net income of US$1.77 billion, alongside higher earnings per share versus the prior year. The company also issued upbeat third-quarter guidance, projecting US$9.30 billion to US$9.40 billion …

Amphenol (APH) Stock Can Record Margins Keep This AI Run Going

Amphenol (APH) saw its shares jump 6.3% after reporting record Q2 2026 revenue of US$8.76 billion and Basic EPS of US$1.44, driven largely by AI-related products in its IT datacom segment. The company's adjusted operating margin reached 29.8%, and strong free cash flow indicates …

Amphenol Q2 Earnings Call Highlights AI Connectivity Growth

Amphenol Corporation APH delivered record second-quarter results as accelerating demand for AI infrastructure, strong order activity and acquisition benefits supported broad-based growth. Management highlighted expanding opportunities across high-speed interconnect, optics and power solutions. Amphenol reported adjusted earnings per share (EPS) of $1.35, beating the …

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for

Analysts expect Amphastar Pharmaceuticals (AMPH) to report a year-over-year decline in earnings for Q2 2026, despite a projected increase in revenues. The Zacks Earnings ESP indicates a potential negative surprise for AMPH, compounded by a Zacks Rank of #5 (Strong Sell). In contrast, Supernus …

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced it will release its second-quarter 2026 financial results after market close on Thursday, August 6, 2026. The company will also host a conference call at 2:00 p.m. Pacific Time on the same day to discuss these results. Investors …

Amphastar Pharmaceuticals Inc (AMPH) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of Amphastar Pharmaceuticals Inc (AMPH)'s financial health, indicating a stable financial status and high operating efficiency with a current score of 8.70. The company reported a significant year-over-year increase in net profit by 74.61%, despite a modest revenue increase …

Amphastar Pharmaceuticals (AMPH) Projected to Release Quarterly Earnings on Thursday

Amphastar Pharmaceuticals (AMPH) is expected to release its Q2 2026 earnings after market close on Thursday, August 6th, with analysts projecting $0.66 EPS and $179.9210 million in revenue. The company previously missed Q1 2026 consensus estimates, reporting $0.42 EPS against an anticipated $0.70. Institutional …

Cómo los resultados por encima de lo esperado impulsados por la IA y las sólidas perspectivas para el tercer trimestre de Amphenol (APH) han cambiado su perspectiva de inversión

Amphenol Corp (APH) (Q2 2026) Earnings Call Highlights: Record Sales, Surging AI Demand, and ...

This article first appeared on GuruFocus. Revenue: Record sales of $8.8 billion, up 55% in US dollars, 54% in local currencies, and 30% organically year-over-year. Orders: Record orders of $10.732 billion, up 94% year-over-year, with a book-to-bill ratio of 1.23:1. Adjusted Operating Margin: Record …

Amphenol Earnings: Impressive Results Continue to Contradict Market's Optics Pessimism

Amphenol (APH) reported Q2 results significantly exceeding guidance, with sales soaring 55% year over year to $8.8 billion and non-GAAP operating margin increasing by 420 basis points to 29.8%. The company's strong performance continues to defy market pessimism regarding the optics sector. Future guidance …

Amphenol Is Best-of-Breed in Interconnect With Surging Growth From AI

Morningstar views Amphenol as a differentiated and exceptional connector supplier, with strong operational capabilities and shareholder capital stewardship. The company's diverse end markets enable top-line expansion even during individual market downturns. Amphenol's effective cost controls contribute to its industry-leading operating margins, allowing it to …

Here is Why Growth Investors Should Buy Amphenol (APH) Now

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock. That's because, these stocks usually carry above-average risk and volatility. In …